Zobrazeno 1 - 10 of 57 pro vyhledávání: '"Isabelle Cadron"'
2
The 'Leuven' paclitaxel/carboplatin weekly regimen in patients with recurrent ovarian cancer, a retrospective study
Autor: Patrick Berteloot, Evelyn Despierre, Karin Leunen, Frédéric Amant, Leyla Abdulkadir, Patrick Neven, Isabelle Cadron, Ignace Vergote
Publikováno v: Gynecologic oncology, 128(1), 34-37. Academic Press Inc.
Objective. To evaluate the "Leuven" weekly paclitaxel/carboplatinum (TC) regimen in recurrent ovarian cancer in a retrospective study. Methods. Eighteen courses of paclitaxel (60 mg/m(2)) and carboplatinum (AUC 2.7) were administered weekly. Platinum
Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::247ae0febef05b4e8e37c7a884543869
https://doi.org/10.1016/j.ygyno.2012.10.004
Zobrazit plný text záznamu
3
Subjective assessment by ultrasound is superior to the risk of malignancy index (RMI) or the risk of ovarian malignancy algorithm (ROMA) in discriminating benign from malignant adnexal masses
Autor: Ignace Vergote, Toon Van Gorp, Karin Leunen, Joan Veldman, Frédéric Amant, Ben Van Calster, Dirk Timmerman, Isabelle Cadron
Publikováno v: European journal of cancer (Oxford, England, 48(11), 1649-1656. Elsevier Limited
European Journal of Cancer, 48(11), 1649-1656. ELSEVIER SCI LTD
Purpose: The combination of two tumour markers, CA125 and HE4, in the risk of ovarian malignancy assay (ROMA) has been shown to be successful in classifying patients into those who have a high or low risk of epithelial ovarian cancer. In the present
Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::a0756c7756eedda71de733aabdcce737
https://cris.maastrichtuniversity.nl/en/publications/959faaad-43fe-4435-8899-0926bc82de29
Zobrazit plný text záznamu
4
Evaluation of paclitaxel/carboplatin in a dose dense or weekly regimen in 66 patients with recurrent or primary metastatic cervical cancer
Autor: Ignace Vergote, Frédéric Amant, Sofie Torfs, Patrick Berteloot, Karin Leunen, Isabelle Cadron
Publikováno v: European journal of cancer (Oxford, England, 48(9), 1332-1340. Elsevier Limited
Background and aims: To evaluate paclitaxel/carboplatin in a dose dense (TCdd) and weekly (TCw) regimen in recurrent or primary metastatic cervical cancer. Methods: Six courses of paclitaxel (90 mg/m(2)) and carboplatin (area under the curve (AUC) 4)
Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::450a169cbb9aedf20dd3ba900b5ab107
https://doi.org/10.1016/j.ejca.2012.01.006
Zobrazit plný text záznamu
5
Gynecologic Oncology Training Systems in Europe
Autor: Murat Gultekin, Polat Dursun, Boris Vranes, Rene Laky, Michaela Bossart, Jacek P. Grabowski, Jurgen M. J. Piek, Ranjit Manchanda, Christoph Grimm, Kastriot Dallaku, Syuzanna Babloyan, Anna Moisei, Toon Van Gorp, Isabelle Cadron, Peter Markov, Ana Micevska, Michael Halaska, Karina Dahl Steffensen, Liidia Gristsenko, Ritva Nissi, Eric Lambaudie, Zaza Tsitsishvili, Dimitrios Haidopoulos, Dimitrios Tsolakidis, Zoltan Novak, Michele Peiretti, Gauhar Dunenova, Ronalds Macuks, Thea E. Hetland, Trond M. Michelsen, Filipe C. Martins, Patriciu Achimas-Cadariu, Elena A. Ulrikh, Peter Uharcek, Sladjana Malic, Dejan Ognjenovic, Ignacio Zapardiel, Silke Johann, Vladyslav S. Sukhin
Publikováno v: International Journal of Gynecological Cancer, 21(8), 1500-1506. Wolters Kluwer Health
Gultekin, M, Dursun, P, Vranes, B, Laky, R, Bossart, M, Grabowski, J P, Piek, J M J, Manchanda, R, Grimm, C, Dallaku, K, Babloyan, S, Moisei, A, Van Gorp, T, Cadron, I, Markov, P, Micevska, A, Halaska, M, Steffensen, K D, Gristsenko, L, Nissi, R, Lambaudie, E, Tsitsishvili, Z, Haidopoulos, D, Tsolakidis, D, Novak, Z, Peiretti, M, Dunenova, G, Macuks, R, Hetland, T E, Michelsen, T M, Martins, F C, Achimas-Cadariu, P, Ulrikh, E A, Uharcek, P, Malic, S, Ognjenovic, D, Zapardiel, I, Johann, S & Sukhin, V S 2011, ' Gynecologic Oncology Training Systems in Europe A Report From the European Network of Young Gynaecological Oncologists ', International Journal of Gynecological Cancer, vol. 21, no. 8, pp. 1500-1506 . https://doi.org/10.1097/IGC.0b013e3182202d17
Gultekin, M, Dursun, P, Vranes, B, Laky, R, Bossart, M, Grabowski, J P, Piek, J M J, Manchanda, R, Grimm, C, Dallaku, K, Babloyan, S, Moisei, A, Van Gorp, T, Cadron, I, Markov, P, Micevska, A, Halaska, M, Steffensen, K D, Gristsenko, L, Nissi, R, Lambaudie, E, Tsitsishvili, Z, Haidopoulos, D, Tsolakidis, D, Novak, Z, Peiretti, M, Dunenova, G, Macuks, R, Hetland, T E, Michelsen, T M, Martins, F C, Achimas-Cadariu, P, Ulrikh, E A, Uharcek, P, Malic, S, Ognjenovic, D, Zapardiel, I, Johann, S, Sukhin, V S & Manchanda, R 2011, ' Gynecologic oncology training systems in europe: a report from the European network of young gynaecological oncologists ', International Journal of Gynecological Cancer, vol. 21, no. 8, pp. 1500-6 . https://doi.org/10.1097/IGC.0b013e3182202d17
International Journal of Gynecological Cancer, 21(8), 1500-1506. BMJ Publishing Group
Objective: The objectives of the study were to highlight some of the differences in training systems and opportunities for training in gynecologic oncology across Europe and to draw attention to steps that can be taken to improve training prospects a
Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::3f03ef8569da2f87d1539106b3df2e85
https://doi.org/10.1097/igc.0b013e3182202d17
Zobrazit plný text záznamu
6
Δ133p53 is an independent prognostic marker in p53 mutant advanced serous ovarian cancer
Autor: Hanno Ulmer, Gerda Hofstetter, Jalid Sehouli, Elena-Ioana Braicu, Ignace Vergote, Robert Zeillinger, Andrea Wolf, Paul Speiser, Eva Schuster, Nicole Concin, Gudrun Hager, A Berger, Isabelle Cadron, AG Zeimet, Christian Marth, Sven Mahner
Publikováno v: British Journal of Cancer
Epithelial ovarian cancer still carries a high mortality rate and remains the leading cause of gynecologic cancer death in the USA, despite decades of research. Hence, there is considerable interest in developing biomarkers that could be used to stra
Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::33c0a5c80b452f11f21b50ab6a3af76a
https://doi.org/10.1038/bjc.2011.433
Zobrazit plný text záznamu
7
HE4 and CA125 as a diagnostic test in ovarian cancer: prospective validation of the Risk of Ovarian Malignancy Algorithm
Autor: Karin Leunen, B. De Moor, Ignace Vergote, Dirk Timmerman, Isabelle Cadron, T Van Gorp, Frédéric Amant, E Despierre, Anneleen Daemen
Publikováno v: British Journal of Cancer, 104(5), 863-870. Nature Publishing Group
British Journal of Cancer
British journal of cancer, 104(5), 863-870. Nature Publishing Group
BACKGROUND: Recently, a Risk of Ovarian Malignancy Algorithm (ROMA) utilising human epididymis secretory protein 4 (HE4) and CA125 successfully classified patients as presenting a high or low risk for epithelial ovarian cancer (EOC). We validated thi
Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::5b2dbd49e696d24b5084901c316e2ee5
https://doi.org/10.1038/sj.bjc.6606092
Zobrazit plný text záznamu
8
The impact of enzastaurin (LY317615.HCl) on CA125 biosynthesis and shedding in ovarian cancer cells
Autor: Karin Leunen, Ignace Vergote, Frédéric Amant, Toon Van Gorp, Katrien Drijkoningen, Isabelle Cadron, Catherina Luyten, Attila Mihalyi
Publikováno v: Gynecologic Oncology, 118(1), 64-68. Elsevier Science
Gynecologic oncology, 118(1), 64-68. Academic Press Inc.
Background. In this study the modulatory effect of the proteinase kinase C beta (PKC beta) selective inhibitor enzastaurin on CA125 expression and shedding in ovarian cancer cells (OVCAR-3 cells) was investigated. Material and methods. OVCAR-3 cells
Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::e893c4469eb8112ecdf48297a36a38d0
https://doi.org/10.1016/j.ygyno.2010.03.008
Zobrazit plný text záznamu
9
Intraperitoneal chemotherapy in patients with advanced ovarian cancer: The con view
Autor: Ignace Vergote, Frédéric Amant, Karin Leunen, Isabelle Cadron, Toon Van Gorp, Patrick Berteloot, Patrick Neven
Publikováno v: oncologist, 13(4), 410-414. AlphaMed Press
Learning Objectives After completing this course, the reader will be able to: Assess the rationale behind using i.p. chemotherapy for epithelial ovarian cancer patients and critically evaluate the data supporting its use.Interpret the argument that i
Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::c8b9edab314570d1d5b9e46b77029887
https://doi.org/10.1634/theoncologist.2007-0224
Zobrazit plný text záznamu
10
Robotic retroperitoneal lower para-aortic lymphadenectomy in cervical carcinoma: First report on the technique used in 5 patients
Autor: Frédéric Amant, Ignace Vergote, Patrick Neven, Isabelle Cadron, Karin Leunen, Bernard Vanacker, Bram Pouseele, Toon Van Gorp
Publikováno v: Acta obstetricia et gynecologica Scandinavica, 87(7), 783-787. Wiley-Blackwell
Objective. Retroperitoneal para-aortic laparoscopic lymphadenectomy is a technically challenging operation. The robotic Da Vinci system might be valuable in this operation due to a steady three-dimensional visualization, instrumentation with articula
Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::83dd603e74a62ea7b7ca6efd744bb206
https://doi.org/10.1080/00016340802146946
Zobrazit plný text záznamu

Vyhledávací nástroje:

Upřesnit hledání

Omezení vyhledávání
Plný text Recenzováno Digitální knihovna AV ČR
Zdroje